Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > pan can protocols
View:
Post by inthno on Sep 06, 2023 3:30pm

pan can protocols

So a quick question for all that I have been pondering.....If and that is a big if the definitive agreements are signed within the 90 days, then why will it most likely take up to another 6 months for the phase 3 trial to start when all the sites and patients are basically already in place.....
Is it possibly because the company thinks that it will take that long to get a partner on board and pick a ci.
I am just trying to understand better as I know that the process is completely different if you are starting new.

Comment by Hydroqc on Sep 06, 2023 6:25pm
There will certainly be the FDA delay to get the trial protocol approuved. It could also be that PAN CAN have limited yearly budget, 30 m, if I recall. It could be that it is in their 2024 budget plan.
Comment by canadafan on Sep 06, 2023 6:35pm
First, when & where does it say phase 3 trial will take an a additional 6 months? The verbiage was " PanCan will enable expiedient phase 3 enrolment" Not sure how or where you come up with the " most likely":idea of a timeline. Point being, until the final parameters are defined, predicting a start date is impossible. Could be .......anytime suggested. That will come out ...more  
Comment by inthno on Sep 06, 2023 8:08pm
Hello CanadaFan,,,,I was kinda extrapolating from the pan can pr which states Oncolytics expects to finalize the definitive agreements within the next 90 days and open the Precision Promise investigational treatment of pelareorep, checkpoint inhibitor, gemcitabine, and nab-paclitaxel in early 2024. My point is that I expect early 2024 to be most likely 1st quarter 2024 which to onc is early and ...more  
Comment by Buckhenry on Sep 06, 2023 9:54pm
Everyone makes assumptions and extrapolates on here....and I took everyone at their word here... say it ain't so...  
Comment by Noteable on Sep 07, 2023 4:27pm
Finalization of agreements with the Pan Can Precision Promise team is this month (September 2023) as Kirk Look stated during the Q2 financials corporate call, unless I somehow didnt hear him correctly, which I think I did.
Comment by inthno on Sep 07, 2023 11:02pm
Hello Noteable and I hope you are right as I remember Kirk saying that at the cc presentation on the Friday and then on Monday August 14th (3 days later) for the quarterly cc this is a quote from Matt as I have the transcript.I had the transcript for the Friday fireside chat with Cannacord but cannot find that but I do agree that Kirk said at that time that he expected September. Our plan for ...more  
Comment by Noteable on Sep 08, 2023 9:18am
The operative wording is " .. by the fourth quarter of this year..". NOT " in the fourth quarter" as you posted.  ,"By the fourth quarter of this year" means sometime in Q3, 2023. Kirk Look stated that would be sometime in September. 90 days fron ONCY'S June 22nd guidance statement is September 22, 2023.
Comment by Normandt on Sep 08, 2023 11:43am
ithno/dreamer/theman/whatever all the other pseudonyms you hide behind.....stop twisting reported words, finding the comma that makes you doubt, extrapolating deadlines without knowing, calling a guideline which is actually an estimate....we know what you are always trying to do, mislead people, while pretending that you are on the side of investors who believe in pela.  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities